fbpx
October 13, 2021

New Approval in Early Breast Cancer: First Advance in 20 Years New Approval in Early Breast Cancer: First Advance in 20 Years

The CDK4/6 inhibitor abemaciclib (Verzenio) has been approved for use in early breast cancer for certain patients. One expert has described the drug as the first […]
October 13, 2021

US FDA Gives Marketing Nod to an e-Cigarette for the First Time US FDA Gives Marketing Nod to an e-Cigarette for the First Time

(Reuters) – The U.S. Food and Drug Administration (FDA) on Tuesday allowed British American Tobacco Plc (BAT) to market its Vuse Solo e-cigarettes and tobacco-flavored pods, […]
October 12, 2021

USPSTF Rules Out Aspirin for Over 60s in Primary CVD Prevention USPSTF Rules Out Aspirin for Over 60s in Primary CVD Prevention

New draft recommendations from the US Preventive Services Task Force (USPSTF) on the use of aspirin for the primary prevention of cardiovascular disease (CVD) have been […]
October 8, 2021

FDA Issues Warning About Use of Fillers With Needle-Free Devices FDA Issues Warning About Use of Fillers With Needle-Free Devices

The Food and Drug Administration issued a warning today about the use of needle-free devices for injecting dermal fillers — which are promoted to the public on social […]
October 8, 2021

FDA Approves Avacopan for Rare ANCA Autoimmune Disease FDA Approves Avacopan for Rare ANCA Autoimmune Disease

US regulators approved avacopan (Tavneos) for a rare immune disorder after receiving additional information to address concerns raised about the drug that were previously discussed at […]
October 4, 2021

FDA Approves First CAR T-Cell for Adult ALL FDA Approves First CAR T-Cell for Adult ALL

The US Food and Drug Administration (FDA) has approved brexucabtagene autoleucel (Tecartus) for the treatment of adult patients (18 years and older) with relapsed or refractory […]
September 29, 2021

Mirum’s Oral Drug Becomes First US-Approved Alagille Syndrome Therapy Mirum’s Oral Drug Becomes First US-Approved Alagille Syndrome Therapy

Mirum Pharmaceuticals Inc said its drug became the first U.S. approved therapy for treating itching in patients with rare liver disorder Alagille syndrome (ALGS), and would be […]
September 27, 2021

‘Alarming’ Increase in Fake Pills Laced With Fentanyl, Meth ‘Alarming’ Increase in Fake Pills Laced With Fentanyl, Meth

The US Drug Enforcement Administration (DEA) has issued a public safety alert over an “alarming” increase in fake prescription pills laced with the synthetic opioid fentanyl […]
September 24, 2021

FDA Okays Evolocumab Add-On for FH in Children Aged 10 and Up FDA Okays Evolocumab Add-On for FH in Children Aged 10 and Up

The US Food and Drug Administration (FDA) has approved evolocumab (Repatha, Amgen), a PCSK9 inhibitor, for use as add-on treatment to diet alone or with other […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0